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Slllmmal'y 
IFN-'y-induced nitric oxide (NO) in the murine macrophage-derived cell line RAW 264.7 was 
previously shown to inhibit replication of the poxviruses ectromelia and vaccinia (VV) and HSV-1. 
In the current study we demonstrate that murine macrophages activated  as a consequence of 
VV infection express inducible nitric oxide synthase. These activated macrophages were resistant 
to infection with VV and efficiently blocked the replication of VV and HSV-1 in infected by- 
stander  cells of epithelial and fibroblast  origin.  This inhibition was arginine dependent, cor- 
related with nitrite production in cultures, and reversible by the NOS inhibitor N'~-monomethyl  - 
r-arginine.  NO-mediated inhibition of VV replication was studied by treatment of virus-infected 
human 293 cells with the NO donor S-nitroso-N-acetyl-penicillamine.  Using a VV-specific DNA 
probe, antibodies specific for temporally expressed viral proteins, and transmission electron mi- 
croscopy, we have shown that NO inhibited viral late gene protein synthesis, DNA replication, 
and virus particle formation, but not expression of the early proteins that were analyzed. Putative 
enzymatic targets of NO were identified by reversing the NO-mediated inhibition of VV replica- 
tion in the 293 cells with exogenous ferrous sulfate and t-cysteine. Reversal of inhibition may 
derive from the capacity of these reagents to protect or regenerate nonheme iron or thiol groups, 
respectively, which are essential for the catalytic activities of enzymes susceptible to inactivation 
by NO. 
T 
he successful elimination of viral infection is dependent 
on both innate and acquired immunity. Macrophages, 
strategically placed in various body compartments, play a key 
role in the orchestration of both innate and antigen-specific 
immune responses.  Apart  from  their  role  as  phagocytic 
scavengers of infectious agents,  macrophages can stimulate 
the antiviral  activities  of NK and T  cells. Together, these 
effector cells and the cytokines they produce act to limit virus 
multiplication before the induction of antigen-specific T cell- 
mediated immunity and antibody responses. By their capacity 
to produce IFNs and other cytokines, NK and T  cells are 
responsible for a reciprocal activation of macrophages. Of the 
IFNs, IFN-y is the most potent macrophage-activating  factor 
and the only known cytokine with the capacity  to induce 
nitric oxide synthase (iNOS) 1 in macrophages by itself (1). 
1 Abbreviations used in thispaper: D-A and L-A, D- and L-arginine, respec- 
tively;  D-NMA  and  L-NMA,  N~-monomethyl-D-arginine and  N ~- 
monomethyl-t-arginine, respectively; EV, ectromelia virus; iNOS, induc- 
ible nitric oxide synthase; METC, mitochondrial electron transport chain; 
NAP, N-acetyl-penicillamine; NO, nitric oxide; PAS, protein A-Sepharose; 
p.i., postinfection; RR, ribonucleotide reductase; SNAP, S-nitroso-N-acetyl- 
penidlhmine; TCA, tricarboxylic acid; TGB, thioglycolate broth; W, vac- 
cinia virus. 
This is an inducible isoform of the enzyme that catalyzes the 
synthesis  of large amounts of nitric oxide (NO) from the 
guanidino nitrogen of t-arginine (t-A)  (1-6). 
IFN-3~-induced high output NO is known to have potent 
antimicrobial activity against several classes of pathogens (2). 
Although IFN-3~ alone is sufficient to induce iNOS (1, 7, 
8), it can synergize with TNF-o~ and -~ to stimulate iNOS 
induction (2). These cytokines by themselves are not able to 
induce the enzyme (1). It was recently demonstrated that IFN- 
3~-induced iNOS inhibited progeny production of the pox- 
viruses ectromelia virus (EV), vaccinia virus (W), and HSV-1 
in the murine macrophage cell line RAW 264.7 and in mu- 
rine peritoneal macrophages (9-11). Thus, in addition to the 
direct lysis of virus-infected cells, NK and T cells can inhibit 
viral replication indirectly by stimulating the IFN-3~-induced 
synthesis of NO in macrophages. 
NO has a short half-life and can diffuse easily across cell 
membranes with no requirement for receptors. As a ubiqui- 
tous intraceUular and intercellular second messenger, it is an 
important mediator of physiologic and pathophysiologic func- 
tions (2, 3, 5, 12, 13). At the molecular level, NO is known 
to inhibit enzymes that require iron and sulfur prosthetic 
groups for their catalytic activity by forming nitrosyl-iron- 
sulfur complexes (2,  14,  15). Enzymes that are targets for 
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(TCA) cycle (16), NADH:ubiquinone oxidoreductase (com- 
plex I), and succinate:ubiquinone oxidoreductase (complex 
II) of the mitochondrial electron transport chain (METC) 
(5, 17-19). NO can also inhibit ribonudeotide reductase (RR), 
the rate limiting enzyme in DNA synthesis (20,  21). 
Recently, in a study of the macrophage-derived cell line 
RAW 264.7, biochemical analyses of virus-infected cells re- 
veahd that viral DNA synthesis and late gene expression were 
blocked by IFN-'y-induced NO (11). These results defined 
the developmental stage in the viral life cycle targeted by NO. 
The current study was performed to elucidate the mecha- 
nism(s) of NO-mediated inhibition of viral replication in vivo. 
At the cellular level, virus-elicited NO-producing peritoneal 
macrophages were tested for their capacity to impair viral 
replication in infected bystander cells. This mode of NO ac- 
tion could be important in vivo to limit viral replication in 
contiguous cells before the action of antiviral T cells and an- 
tibodies. At the molecular level, biochemical analyses were 
done to determine how viral protein synthesis was affected 
in infected cells by chemically generated NO, and to identify 
enzymatic targets of inactivation by NO. 
Materials and Methods 
Mice.  Female  specific pathogen-flee,  BALB/c NCR (H-2  a) 
mice (Charles River Laboratories, Wilmington, MA) were used 
at 6-12 wk of age. 
Viruses.  A sucrose  density gradient-purified WR strain of VV 
(VV-WR and ATCC VR1354; American Type Culture Collection, 
Rockville, MD) was used for inoculation of mice. A crude stock 
of VV-WR propagated in BS-C-1 cells was used for infection of 
cell cultures in vitro. The inocula, diluted in PBS to contain 107 
pfu/ml (purified stock) or 106 pfu/ml (crude stock), had no de- 
tectable endotoxin (<10 pg/ml) by a chromogenic limulus amebo- 
cyte lysate assay  (BioWhittaker Inc., Walkersville,  MD). The KOS 
strain of HSV-1, a gift from Dr. M. Challberg (Laboratory  of Viral 
Diseases, National Institute of  Atlergy and Infectious  Diseases, Na- 
tional Institutes of Health, Bethesda, MD) was propagated in BS- 
C-1 ceils. 
Cells.  BS-C-1, an African green monkey kidney cell line, and 
293, a human renal epithelial  line, were maintained in Eagle's MEM 
(EMEM; BioWhittaker Inc.) supplemented with t-glutamine, an- 
tibiotics, and 10% FCS (complete EMEM). The preparation of pri- 
mary murine ovarian  cell cultures has been described  elsewhere  (22). 
Primary murine uterine cells were prepared similarly,  and both cul- 
tures were used after two or three serial passages. 
Reagents.  t-A,  D-arginine (D-A), t-NMA, N~-monomethyl-D  - 
arginine  (r~-NMA), N-acetyl-penicillamine (NAP), t-cysteine, 
isocitric acid, and c~-ketogtutaric  acid were obtained from Sigma 
Immunochemicals (St. Louis, MO). S-Nitroso-N-acetyl-penicilla- 
mine (SNAP) was obtained from Biomol Research Laboratories 
(Plymouth Meeting, PA). FeSO4 was purchased from Mallinck- 
rodt  (St. Louis, MO). 
Transmission Electron Microscopy.  Medium was removed  from cul- 
tures, and cells were fixed for 30 rain with 2.5% gluteraldehyde 
in Millonig's sodium phosphate buffer, pH 7.9, at 4~  after which 
cells were scraped and centrifuged at 500 g. Fixation of the cell 
pellet was continued for an additional 90 rain at 4~  after which 
the fixative  was aspirated and replaced with sodium phosphate buffer 
lacking gluteraldehyde.  Samples were stored at 4~  until processed 
for transmission electron microscopy. 
Determination of  Progeny Virus Titers.  Virus  infectivity  in infected 
cell cultures was determined as described elsewhere (10, 23). 
Cocultgre of VV-elicited  Peritoneal  Macroykages with VVqnfected Trans- 
formed(Human 293) or Primary (Murine Ovarian, Uterus) Cells.  Virus- 
elicited peritoneal macrophages were harvested 5 d after i.p. inocu- 
lation of BALB/c mice with 106 pfu of VV-WR. Approximately 
25% of these cells are macrophages based on adherence to plastic 
and cell surface expression of both Mac-1 and F4/80 antigens as 
determined by flow cytometry. Thioglycolhte broth (TGB)-ehcited 
peritoneal macrophages were obtained from BALB/c mice 3-4 d 
after i.p. injection with 2 ml of sterile broth (<10 pg of endotoxin 
per ml). Wells of 24-cluster plates were seeded  with an appropriate 
number of peritoneal cells in complete RPMI such that about 106 
adherent cells remained after nonadherent cells were removed after 
incubation at 37~  for 1 h. Nonadherent cells were removed by 
vigorous washing with cold PBS three times, and they were enumer- 
ated to obtain a fairly accurate number of adherent cells that re- 
mained in the wells. These macrophages were cocuttured with in- 
fected target cells at a ratio of 5:1 in the presence or absence of 
various reagents. 
Nitrite and NOS Assays.  NO synthesis in cultures was deter- 
mined by measurement of nitrite (NO~-), a stable product of NO, 
as described elsewhere (1). For the determination of NOS activity, 
crude cytosolic fractions (30 mg) prepared from TGB- and VV- 
elicited peritoneal macrophages were used in an assay  described else- 
where (24). 
Metabolic  Labeling  of  Viral  Proteins.  Calls were grown  to 
subconfluency (10  6 cells per well) in 12-well cluster plates (Costar 
Corp., Cambridge, MA). The medium was aspirated, and the cells 
were washed with PBS. 1 ml of methionine-free EMEM sup- 
plemented with 5% dialyzed FCS and 30 #Ci of [3SS]methionine 
(>1,000 Ci/mmol; Amersham Corp., Arlington Heights, IL) were 
added to each well. After labeling, medium was aspirated, and the 
cells were washed with PBS, harvested in 1 ml of PBS, and cen- 
trifuged in a bench-top centrifuge. After PBS was aspirated, cells 
were lysed  in 200 #1 oflysis buffer (2% Triton X-100, 50 mM Tris- 
HC1, pH 7.4, 100 mM NaC1, 1 mM EDTA, pH 7.4). Incorpora- 
tion of [3SS]methionine was determined by TCA precipitation of 
labeled proteins onto nitrocellulose membrane and measurement 
with a ~/scintillation counter. Metabolically  labeled proteins were 
analyzed by SDS-PAGE (10% acrylamide)  and fluorography (Am- 
plify; Amersham Corp.). 
Quantification of Viral DNA.  At the end of culture period, 
medium was aspirated from wells of 293 cell monolayers,  and cells 
were scraped and resuspended in 200/~1 of PBS. The cells were 
lysed by three cycles of freeze (-70~  and thaw (37~  and soni- 
cated (two 60-s pulses, W-385 sonicator; Heat-Systems-Ultrasonics, 
Inc., Farmingdale, NY). The DNA was denatured with 0.25 M 
NaOH for 10 min at room temperature, and the lysates  were then 
kept on ice, diluted to 0.2 M NaOH, 0.1  x  SSC, and sonicated 
as previously  described. A 100-/zl  volume  of  each sample was blotted 
onto a nylon membrane (Genescreen Plus; Dupont-NEN,  MA) 
using a slot blotter (Minifold II; Schleicher  & Schuell, Inc., Keene, 
NH). The membrane was incubated  in prehybridization  buffer (1% 
SDS, 1 M NaC1, 200/xg/ml herring sperm DNA) for 15 min at 
65~  Denatured, radiolabeled VV DNA probe (Random Primer 
DNA Labeling  Kit; Boehringer Mannheim, Indianapolis, IN) was 
added to the prehybridization medium, and the blot was incubated 
overnight at 65~  The hybridized blot was washed twice with 
2x  SSC (5 min, room temperature) and then with 2x  SSC, 1% 
SDS (30 rain at 65~  The radiolabled DNA probe hybridized 
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(ATC Diagnostics, Inc., Framingham, MA). 
Imraunop'rcipitation.  The W  early gene products, E3L and K1L, 
were immunoprecipitated using mAb TW2.3 (25) (gift from Dr. 
J. Cox, SKA Technologies Inc., Rockville, MD) and a rabbit poly- 
clonal antibody (gift from Dr. K. Drillien, INSERM, Strasbourg, 
France),  respectively. Rabbit polyclonal  antibodies  were used to 
immunoprecipitate the viral late gene products of 65 kD (26) and 
70 kD (also known as 4b; reference 27). Antibodies (1-5 #1) were 
incubated with 50 #1 of  protein A-Sepharose (PAS; 20% [vol/vol]; 
Sigma Immunochemicals) for I h at 4~  with agitation. The PAS 
suspension was centrifuged briefly, the supematant was aspirated, 
and the PAS pellet was washed with PBS before being resuspended 
with precleared cell lysate. Cell lysates were precleared by incuba- 
tion with 2 #1 of preimmune serum, 4% PAS, and PBS in a final 
volume of 250 gl for 1 h at 4~  with agitation. This precleared 
lysate was used to resuspend  the pellet  of antibody-bound PAS. 
The lysate and antibody-bound PAS suspension were incubated for 
4 h at 4~  with agitation. After centrifugation, the lysate was aspi- 
rated, and the PAS was washed twice with PBS. Protein was eluted 
from the PAS with 20 ~1 of PAGE sample buffer (62.5 mM Tris- 
HC1,  pH  6.8,  containing  2%  SDS, 10%  glycerol,  0.0025% 
bromophenol blue,  and 5%  2-ME).  The samples were heated  at 
100~  for 5 rain, centrifuged briefly, and analyzed by PAGE and 
fluorography. 
Detection ofiNOS by Immunoblotting.  Cell lysates (30 #g of pro- 
tein; Bradford method; Bio Rad Laboratories, Richmond, CA) (for 
lysate preparation see Metabolic  Labeling of Viral Proteins)  were 
resolved by SDS-PAGE on a 4-20%  gradient gel (Daiichi  Pure 
Chemicals,  Tokyo, Japan) and probed with a rabbit polyclonal an- 
tibody (anti-NO16; a gift from Dr. C. Nathan, Cornell University 
Medical College, New York) to the COOH-terminal peptide (Cys- 
Nle-Glu-Glu-Pro-Lys-Ala-Thr-Arg-Leu-COOH; synthesized by Drs. 
J. Weidner and R. Mumford, Merck Research Laboratories, Rahway, 
NJ), derived from the long form of  mouse macrophage iNOS (28). 
The protein was detected by chemiluminescence (Amersham Corp.) 
and autoradiography. 
Results 
VV Infection of Mice  Induces iNOS  in Peritoneal Macro- 
phages.  Previous work (10) indicated that a NO-mediated 
antiviral mechanism(s) may be operative in poxvirus-infected 
mice. To establish  that iNOS is induced in macrophages in 
vivo after infection, we analyzed lysates of peritoneal macro- 
phages obtained from mice infected i.p. with VV. Using an 
antipeptide antibody to murine macrophage iNOS in Western 
blot analysis, iNOS was detected in the VV-elicited macro- 
phages (Fig. 1). The antibody reacted with a protein of •  130 
kD, the molecular mass of macrophage-expressed iNOS. Al- 
though the antibody cross-reacted with other cellular pro- 
teins, no specific reactivity was seen in lysates of TGB-elicited 
macrophages.  The macrophage  iNOS  was biologically ac- 
tive with a specific enzyme activity of 220 pmol'min-l'mg-1 
of cell lysate protein. No activity was detected in the control 
lysate. 
VVelicited Peritoneal Macrophages Inhibit  VV ReFlication in 
Cocultured Contiguous  Cells.  Peritoneal macrophages  from 
mice  infected i.p.  with  VV  did  not  harbor  VV  particles 
(Karupiah, G., and N. Harris, unpublished observations), nor 
did they support viral replication in vitro (data not shown). 
To test whether such virus-elicited,  iNOS-expressing  mac- 
Figure  1.  iNOS  expression  in  VV- 
elicited  peritoneal  macrophages.  Antibody 
specific for iNOS was used to detect the 
protein in lysates  of murine  peritoneal  mac- 
rophages. Virus-elicited  peritoneal macro- 
phages (Air//) and TGB-elicited  peritoneal 
macrophages (MT) were harvested from 
BALB/c mice at 5 and 4 d after i.p. injec- 
tion with 106 pfu of W  and 2 ml of TGB, 
respectively.  Cell lysates  (30/.tg) were frac- 
donated by PAGE, transferred  to nitrocel- 
lulose, and  analyzed with  antibody to 
iNOS. The antigen was detected by the 
ECL system.  The arrow indicates  the posi- 
tion of iNOS, which is ,~130 kD. Protein 
molecular  mass  markers are in kilodahons. 
rophages could inhibit VV replication in neighboring cells, 
VV-infected 293 cells were cocultured with peritoneal mac- 
rophages obtained from mice 5 d after i.p. infection with VV. 
As controls, TGB-dicited macrophages were cocultured with 
infected cells. VV- but not TGB-elicited macrophages reduced 
progeny virus titers by fivefold over 16 h (Fig. 2, A  and B). 
The modest degree of inhibition could have been caused by 
increased arginine metabolism in these activated macrophages 
(29-31),  the metabolite being the limiting factor in the cul- 
tures. Addition of 0.5 mM L-A, but not D-A, reduced progeny 
virus titers by >50-fold. r-NMA, an analogue of L-A and com- 
petitive inhibitor of NOS,  almost completely reversed the 
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Figure  2.  Inhibition  of  VV replication  by VV-elicited  macrophages.  VV- 
elicited  macrophages (harvested  5 d after  i.p.  inoculation  with VV) and 
TGB-clicited  macrophages (harvested  4  d after  i.p.  injection)  were  coculti- 
vated  with  W-infected (I  pill  per  ceil)  human 293  cells.  At  16  h  p.i.,  progeny 
virus  fitcrs  and  nitrite  levels  were  determined.  Cocultures  were  supplemented 
with 0.5  mM  t-A  or  D-A and 1 mM  L-NMA or  D-NMA.  ND, not done. 
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inhibition  of progeny virus production and its reversal by 
L-NMA correlated with levels of nitrite detected in cultures 
(Fig. 2 C). In contrast,  nitrite was barely detectable in cul- 
tures containing TGB-dicited macrophages (Fig.  2 D). 
Coculture of SlCr-labeled, W-infected 293 ceils with VV- 
elicited macrophages indicated that the reduction in progeny 
virus titers was not caused by macrophage-mediated  cyto- 
toxicity, as the levels of radioactivity detected in the cuhure 
medium in the presence  or absence  of  macrophages were com- 
parable (data not shown). Treatment of the adherent perito- 
neal cells with C' plus mAbs to CD4,  CDS,  or both an- 
tigens had virtually no effect on virus titers (data not shown), 
indicating  that the reduction in virus titers was not caused 
by the antiviral action of conventional T cells. Furthermore, 
when VV-elicited macrophages were separated from the in- 
fected 293 cells by a semipermeable membrane, no inhibition 
of viral replication was noted (data not shown). 
All 293 cells examined in coculture with TGB-elicited mac- 
rophages contained large numbers of virus particles (Fig. 3 
A). In contrast, >30% of  293 cells cultured with VV-elicited 
macrophages  contained no virus particles (Fig. 3 B), and those 
that did harbored  significantly fewer particles. This reduc- 
tion in virus particles was nearly completely reversed in cul- 
tures supplemented with 1 mM t-NMA (Fig. 3 C), consis- 
tent with virus progeny titers  (Fig. 2, A  and B). 
VV-elicited  Peritoneal  Macrop~ges  Inhibit VV and HSV1 Repli- 
cation in  Transformed Cells and Primary Murine Tissue Cul- 
tures.  VV replicates most efficiently in murine ovarian and 
uterine cells (22, 32). It was found that VV-elicited perito- 
neal macrophages blocked VV replication in both primary 
murine ovarian (Fig. 4 A) and uterine (Fig. 4 B) cells, and 
the inhibition correlated closely with levels of nitrite produc- 
tion (data not shown),  similar to levels shown in Fig 2 C. 
The replication of HSV-1 in 293 cells was also completely 
abolished when coincubated with VV-elicited macrophages 
(Fig. 4 C), and addition  of 1 mM t-NMA to cultures par- 
tially reversed the inhibition. The results of  both experiments 
attested to the nonspecific nature of macrophage antiviral ac- 
tivity. 
Reversal of  NO-mediated  Inhibition of VV Replication with Ex- 
ogenous FeS04, Isocitrate, and cr-Ketoglutarat~  NO is known 
to inhibit the catalytic activities of  enzymes in the TCA cycle, 
the METC,  and RR, an enzyme critical for DNA metabo- 
lism. The radical gas nitrosylates and inactivates iron-sulfur 
centers in the prosthetic groups  of these enzymes (2). We 
attempted to reverse, or at least relieve,  the inhibition of  puta- 
tive viral targets of NO by providing exogenous ferrous ions 
and thiol groups in cocultures of NO-producing macrophages 
with virus-infected target cells. The efficacy  of these measures, 
however, could not be determined because the addition  of 
thiol groups  alone was without effect whereas FeSO4 was 
toxic to the macrophages. To circumvent the problem of mac- 
rophage toxicity, we used the chemically synthesized com- 
pound SNAP as a source of NO. Treatment of VV-infected 
293 cells with the NO-producing compound, but not the 
control compound (NAP), was shown previously to block 
progeny virus production (10). In a recapitulation of experi- 
Figure  3.  Detection of W  particles  in human 293 cells cocuhivated 
with W-elicited murine peritoneal macrophages by transmission electron 
microscopy. VV-infected 293 cells (1 pfu per cell) cocuhivated with (A) 
TGB-elidted macrophages ( x 5,000), (B) W-elicited  macrophages ( x 5,000), 
and (C) W-elidted macrophages in the presence of 1 mM t-NMA (x 4,000). 
In B, the examined  section  shown here contained no virus particles. 
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NO-mediated inhibition of viral replication  is neither restricted  Figure 4. 
by host cell type, nor is it virus specific. VV-elicited macrophages, har- 
vested 5 d after i.p. inoculation, were cocultivated with (A) VV-infected 
murine ovarian calls (OF'), (B) W-infected murine uterine cells (UT), 
and (C) HSV-l-infected 293 cells (293.-HSV-I). At 16 h p.i., progeny virus 
titers and nitrite levels  in cultures were determined. Cocultures were sup- 
plemented with 0.5 mM r-A, 0.5 mM D-A, 1 mM t-NMA, or 1 mM 
D-NMA. 
ments using the macrophage-derived RAW 264.7 cells treated 
with IFN-7 as a source of NO (11), the radical gas generated 
from SNAP was found to inhibit viral protein synthesis in 
VV-infected 293 cells, whereas the control NAP had no effect 
Figure 5.  Inhibition  of  VV 
protein  synthesis by chemically 
generated NO. Cell lysates were 
made from metabolically labeled 
([3sS]methionine)  uninfected (U) 
and VV-infected (V) human 293 
cells (1 pfu per cell) 16 h p.i. and 
analyzed by PAGE and fluorog- 
raphy. Virus-infected cell cultures 
were treated with 400/~M NAP 
(VN) or SNAP (VS).  Control, 
uninfected cells  were similarly  cul- 
tured in the presence of 400/~M 
NAP (N) or SNAP (S).  Protein 
molecular mass markers (M) are 
in kilodahons. 
(Fig.  5).  With antisera specific for either early or late viral 
proteins,  we confirmed that early genes were expressed in 
NO-treated cells (Fig. 6 A), whereas late gene expression was 
abolished (Fig.  6 B). Using a virus-specific probe, we could 
not detect VV DNA in infected NO-treated cells (Fig. 6 C). 
Consistent with the molecular analyses,  transmission elec- 
tron microscopy revealed that SNAP-treated 293 cells did not 
contain virus particles (data not shown) and had essentially 
the same appearance as uninfected cells  (data not  shown). 
SNAP-treated, VV-infected 293 cell cultures and untreated 
controls were supplemented with FeSO4 and 2  mM t-cys- 
teine, a source of thiol groups. In addition, we predicted that 
inhibition of the TCA cycle enzyme cis-aconitase could be 
circumvented by providing substrates distal to citrate in the 
cycle, namely, isocitrate and/or o~-ketoglutarate. Progeny virus 
yields were not affected significantly in cultures lacking SNAP 
but containing FeSO4, isocitrate,  and c~-ketoglutarate,  com- 
pared with the control (Fig.  7 A).  Treatment with SNAP 
completely abolished progeny virus yields, and the addition 
of isocitrate and ol-ketoglutarate had virtually no effect. How- 
ever, when FeSO4 was  added to  SNAP-treated cultures,  a 
significant reversal (40%; Fig. 7 A) of the inhibition was ob- 
served. This reversal was enhanced further (67%) when both 
isocitrate and o~-ketoglutarate were also included. It was noted 
that addition of only one or the other of these TCA cycle 
substrates was without effect (data not shown). Thus, provi- 
sion of FeSO4,  t-cysteine, and the substrates isocitrate and 
oL-ketoglutarate partially, but significantly, reversed the inhi- 
bition  of viral replication mediated by NO. 
Addition of SNAP to cultures immediately after infection, 
or at any time during the first 4 h postinfection (p.i.), com- 
pletely blocked viral replication, whereas addition at 8 h p.i. 
had minimal effect. A partial block in viral DNA replication 
and progeny production was noted if the NO-generating 
source was added between 4 and 8 h p.i. The degree of inhi- 
bition decreased as the time of addition approached 8 h p.i. 
(Fig.  7 B). The effect of NO on virus progeny yields there- 
fore diminished with time after the initiation of viral DNA 
replication and had no discernible effect after the completion 
of late protein synthesis. 
Discussion 
Macrophage-mediated cytotoxic and cytostatic activities to- 
ward tumor cells and infectious agents have been attributed, 
at least in part, to NO and its reactive intermediates (2, 4, 
17). Recent findings that NO can inhibit the replication of 
a number of viruses (9-11,  33)  have extended the range of 
microbial pathogens targeted by the molecule. In experiments 
designed to test the antiviral properties of NO under physio- 
logic conditions, we demonstrated that W-elicited macro- 
phages blocked viral replication in cocultured virus-infected 
bystander cells.  VV and HSV-1  replication in transformed 
(human 293 epithelial) and nontransformed (primary ovarian 
and uterine) cells was inhibited by NO generated by the acti- 
vated peritoneal macrophages. NO-mediated inhibition of  viral 
replication therefore was neither host cell or virus specific. 
2175  Karupiah and Harris Figure  6.  NO-mediated inhi- 
bition of VV late, but not early, 
gene protein synthesis. (A) Lysates 
of metabolically labeled ([3SS]me- 
thionine) uninfected (L  0 and VV- 
infected (//') 293 cells (1 pill per 
cell)  were  analyzed  with  anti- 
bodies specific for the viral early 
gene proteins E3L (25 and 19 kD; 
indicated  by  arrows  at  left  of 
figure) and KIL (32 kD) 4 h p.i. 
Cells were cultured in the pres- 
ence of 400  #M  SNAP (S),  or 
NAP (N).  (B) Lysates of meta- 
bolically labeled  293  cells  were 
analyzed  with antibody specific  for 
the viral late gene proteins 65 kD 
and 4b (70 kD)  16 h p.i. Treat- 
ment with NAP had no effect on 
viral late gene protein expression 
(data not shown). Protein molec- 
ular  mass  markers  (M)  are  in 
kilodaltons.  (C) Lysates of unin- 
fected, infected  (1 pfu per cell),  and 
NAP/SNAP  (400  /~M)-treated 
293 cells were analyzed at 20 h p.i. 
by filter hybridization using radio- 
labeled VV genomic DNA (3-5 
x  106 cpm per filter). 
The antiviral activity of the virus-elicited macrophages cor- 
roborated results obtained with the macrophage-like RAW 
264.7 cells treated with IFN-3~ (11). In both instances, the 
effector populations, with measurable iNOS activity, blocked 
viral replication in contiguous cells through an r-A-depen- 
dent, NO-mediated pathway. Although IFN-'y may not be 
the only factor reponsible for the induction of iNOS in peri- 
toneal macrophages during VV infection in vivo,  several in 
vitro and in vivo studies strongly suggest that it plays a crit- 
ical role (1,  6-8). 
Although VV-elicited macrophages can lyse certain tumor 
targets (34),  the inhibition of viral replication in both trans- 
formed and nontransformed primary cell cultures was a con- 
sequence of cytostasis,  which may reflect differences in the 
susceptibilities  of tumor  cells  and  vitally infected cells  to 
macrophage-derived NO. Inhibition of viral replication was 
observed only when activated macrophages and virus-infected 
target cells were cultured together. No effect was seen when 
the two populations were separated by a semipermeable mem- 
brane. This requirement for cell-cell contact may be attrib- 
uted to the short half-life and hence limited range of macro- 
phage-derived NO for effector function and could reflect how 
such macrophages operate in vivo. Furthermore, the existence 
of discrete membrane and cytosolic forms of iNOS (35) may 
account for the spatial constraints on effector and target cells 
in  the coculture system. 
Activated macrophages have a prodigious capacity to break 
down L-A to ornithine and urea by the action of t-arginase 
(29-31). Disproportionate arginase production compared with 
iNOS activity, with a resultant depletion of intracellular ar- 
ginine, could arguably account for an inhibition of  viral repli- 
cation.  It was observed,  however, that  supplementing the 
coculture medium with t-A augmented the inhibition of viral 
replication, with a concomitant increase in nitrite produc- 
tion. Inhibition was a corollary of NO production, and ad- 
dition of exogenous LoA served to stimulate the NO biosyn- 
thetic pathway. 
NO that was produced by the chemical compound SNAP 
inhibited W  late gene protein synthesis, VV DNA replica- 
tion, and viral morphogenesis, but had no effect on viral early 
gene protein expression in infected 293 cells. The NO-mediated 
block in virus progeny production appeared to be at the stage 
of viral DNA replication. Similar findings were made in IFN- 
3~-treated  RAW 264.7 cells (11). The results of the kinetic 
study using SNAP as a source of NO to inhibit viral replica- 
tion (Fig 7 B) corroborated the molecular analyses (Fig 6). 
Addition of the compound immediatedly after infection, or 
at 4 h, completely abolished DNA replication. The inhibi- 
tory effect was partially diminished if SNAP was added 4 
h  after infection and was absent at  8  h.  At this time, late 
gene expression has taken place, but since infectious progeny 
are not detectable before 12 h p.i., viral assembly is incom- 
plete. The time course of NO-mediated inhibition therefore 
indicated that it affects viral DNA replication, but it does 
not impinge on viral maturation. 
NO and its reactive intermediates exert a number of their 
diverse biological effects by reacting with transition metal- 
and thiol-containing proteins (36).  Key regulatory enzymes 
of energy metabolism, i.e., c/s-aconitase (TCA cycle), NADH: 
ubiquinone  oxidoreductase,  and  succinate:ubiquinone ox- 
idoreductase (METC), and RR (DNA metabolism), contain 
iron-sulfur centers that are essential for their catalytic activi- 
ties and that have been shown to be targets of nitrosylation 
(14-21).  We used the susceptibility of these critical metabolic 
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Figure 7.  NO-mediated inhibition of viral replication and its reversal 
by exogenous FeSO4, isocitrate, and ~-ketoglutarate. (A) VV-infected 
human 293 cells were cultivated in the presence or absence of the NO- 
producing compound  SNAP (400/xM). Cultures were supplemented with 
2.5 mM r-cysteine, 50/~M FeSO4, 1 mM isocitrate (Iso-C), and 1 mM 
ot-ketoglutarate (et-KG).  SNAP and the other reagents were added at 
0 h p.i., and progeny virus titers were determined at 12 h p.i. (B) SNAP 
(400/xM) was added to VV-infected  human 293 cells at 0, 4, or 8 h p.i., 
and progeny virus titers were determined at 12 h p.i. 
enzymes to nitrosylation to inform the experimental design 
of a mechanistic  study of NO-mediated inhibition  of viral 
replication. We aimed to protect, or repair iron-sulfur centers 
in putative target enzymes with exogenous ferrous ions and 
thiol groups. Studies to date on NO-mediated inhibition of 
enzyme activities have been performed with permeabilized 
ceils, cell lysates,  and purified cell fractions (15,  16,  18-21). 
Pursuant to a physiologically relevant approach to the study 
of NO activity, we used intact,  functionally active cells to 
study the inhibition of viral replication and its reversal.  Ex- 
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ogenous FeS04 alone was found to be toxic to the activated 
macrophages, possibly reflecting documented ferrous ion cyto- 
toxicity (37).  FeSO4 (50/~M) and L-cysteine (2 #M),  how- 
ever,  were found to reverse the chemically generated  NO- 
mediated inhibition of viral replication (40%). Addition of 
the TCA metabolites, ol-ketoglutarate and isocitrate, further 
augmented  the reversal  (67%). 
A regulatory loop has been elucidated between the steady- 
state levels of intracellular  iron and NO (38),  which could 
account for NO-mediated inhibition of viral replication and 
its reversal by exogenous FeSO4.  Although the rectification 
of iron  homeostasis  by  exogenous  FeSO4 could  therefore 
provide an explanation for the reversal  of inhibition of viral 
replication, the experimental evidence suggests a specific effect 
of exogenous ferrous ions  and  thiol  groups  on targets  of 
nitrosylation.  The concentration of FeSO4 at which reversal 
was achieved (50 #M) may have been limiting relative to that 
of the inhibitor SNAP (400/~M).  In addition,  we have de- 
termined that the reversal of inhibition was not a consequence 
of FeSO4 scavenging of NO. The level of nitrite in cultures 
(measured before and after reduction of nitrate to nitrite with 
bacterial nitrate  reductase)  was not  diminished  by FeSO4, 
even when it was added in molar excess (500/~M; data not 
shown). The limiting effective concentration of FeSO4 and 
the absence of NO scavenging suggest strongly the specificity 
of FeSO4  for  targets  of nitrosylation,  but  these  were not 
sufficient to elucidate the nature  of these targets. 
The partial reversal of inhibition suggests that NO is acting 
on multiple cellular and viral pathways, only some of which 
are responsive to the protective action of exogenous ferrous 
ions and thiol groups.  It has been noted, for example, that 
potentially deleterious nitrosylation can occur at nucleophilic 
centers other than iron-sulfur centers,  such as DNA and tyro- 
sine residues (36). In addition to transition metals, NO reacts 
with oxygen and superoxide to generate a second line of reac- 
tive molecules that can attack an extended range of nucleophilic 
targets.  The biological activities of NO and their modula- 
tion must therefore be considered in terms of the reactivities 
of the gas and its reactive products with many and disparate 
targets. 
Antiviral CTLs are important for viral elimination;  how- 
ever, they can only halt further spread of the virus and cannot 
reduce the number of infectious partides already present (39). 
The beneficial effect of CTL-mediated lysis is apparent only 
if infected cells are lysed before assembly of progeny virus. 
If infectious virus was released from infected cells in solid 
tissues before the generation of neutralizing  antibody or at 
sites where antibody did not readily penetrate,  then recruit- 
ment of mononuclear phagocytes,  which phagocytose and 
destroy infectious material and/or become nonproductively 
infected, would help control viral dissemination (40). In this 
context, iNOS induction in macrophages may be an impor- 
tant antiviral  strategy.  In addition, the inhibition of viral repli- 
cation in infected contiguous cells by iNOS-expressing mac- 
rophages at infectious foci would prevent release  of mature 
virus particles after lysis by NK cells and CTLs. Since viral 
early proteins are expressed in such infected cells,  their rec- 
ognition  and lysis by CTLs will not be hindered. The authors thank Drs.  Carl Nathan,  Bernard Moss,  and members of their respective  laboratories,  as 
well as Drs. Herbert C. Morse III and Jack Bennink for helpful comments and suggestions on the manu- 
script.  We are grateful to John MacMicking for assistance in performing the nitrite assays, Drs. Robert 
Drillien, Josephine Cox, Carl Nathan, and Qiao-wen Xie for the antibodies,  and Dr. Christina Cassetti 
for assistance in the presentation of Fig.  1. 
Address correspondence to Dr. Gunasegaran Karupiah, Division of Immunology and Cell Biology, The 
John Curtin School of Medical Research, The Australian  National University, PO Box 334, Canberra 
ACT 2601, Australia. 
Received for publication  I1  November  1994 and in  revised form  3 February  1995. 
R~ferences 
1.  Ding, A.H., C.F. Nathan, and D.J. Stuehr. 1988. Release of 
reactive  nitrogen  intermediates  and  reactive  oxygen inter- 
mediates  from mouse peritoneal macrophages.  J.  Immunol. 
141:2407-2412. 
2.  Nathan, C. 1992. Nitric oxide as a secretory product of mam- 
malian cells. FASEB (Fed. Am. SoL Ex  F Biol.)J. 6:3051-3064. 
3.  Moncada, S., R.M.J.  Palmer, and E.A.  Higgs.  1991. Nitric 
oxide: physiology, pathophysiology, and pharmacology. Phar- 
macol. Rev. 43:109-142. 
4.  Nathan, C.F., and J.B.  Hibbs, Jr.  1991. Role of nitric oxide 
synthesis in macrophage antimicrobial activity. Cu~ Opin. Im- 
munol. 3:65-70. 
5.  Hibbs, J.B., Jr., R.R. Taintor, Z. Vavrin, D.L. Granger, J.-C. 
Drapier, I.J.  Amber, and J.R.  Lancaster.  1990. Synthesis  of 
nitric oxide from a terminal guanidino nitrogen atom of t-argi- 
nine: a molecular mechanism regulating cellular proliferation 
that targets intracellular iron. In Nitric Oxide from t-Arginine: 
A Bioregulatory System. S. Moncada and E.A. Higgs, editors. 
Elsevier Science Publishers,  B.V., Amsterdam.  pp.  189-223. 
6.  Stuehr, D.J., and M.A. Marietta. 1987. Induction of nitrite/ni- 
trate synthesis in murine macrophages by BCG infection, lym- 
phokines, or interferon-',/. J. Immunol.  139:518-525. 
7.  Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, 
and T.A. Stewart. 1993. Multiple defects of immune cell func- 
tion in mice with disrupted interferon-q, genes. Science (Wash. 
DC).  259:1739-1742. 
8.  Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Blueth- 
mann, K. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 
1993.  Immune response in  mice that lack  the interferon-q, 
receptor. Science (Wash. DC).  259:1742-1745. 
9.  Croen, K.D.  1993. Evidence for an antiviral effect of nitric 
oxide. J.  Clin. Invest. 91:2446-2452. 
10.  Karupiah, G., Q.-w. Xie, R.M.L. BuUer, C. Nathan, C. Du- 
arte, and J.D. MacMicking. 1993. Inhibition of viral replica- 
tion by interferon-q,-induced  nitric oxide synase. Science (Wash. 
DC). 261:1445-1448. 
11.  Harris, N., R.M.L. Buller, and G. Karupiah.  1995. Interferon- 
gamma induced, nitric oxide mediated inhibition of vaccinia 
viral replication. J.  Virol. 69:910-915. 
12.  Lowenstein, C.J., and S.H. Snyder. 1992. Nitric oxide, a novel 
biological messenger.  Cell. 70:705-707. 
13.  Lancaster, J.R., Jr. 1994. Simulation of the diffusion and reac- 
tion of endogenously produced nitric oxide. Proc. Natl. Acad. 
Sci. USA.  91:8137-8141. 
14.  Lancaster, J.R., Jr., and J.B. Hibbs, Jr. 1990. EPR demonstra- 
tion of iron-nitrosyl complex formation by cytotoxic activated 
macrophages.  Proc. Natl.  Acad. Sci. USA.  87:1223-1227. 
15.  Pellat, C., Y. Henry, andJ.-C. Drapier.  1990. IFN-'y-activated 
macrophages: detection by electron paramagnetic resonance 
of  complexes between t-arginine-derived nitric oxide and non- 
heine iron proteins.  Biochem. Biophys. Res. Commun.  166:119- 
125. 
16.  Drapier, J.-C., and J.B. Hibbs, Jr. 1986. Murine cytotoxic ac- 
tivated macrophages inhibit aconitase in tumor cells. J. Clin. 
Invest. 78:790-797. 
17.  Stuehr, D.J., and C.F. Nathan.  1989. Nitric oxide. A macro- 
phage product responsible for cytostasis and respiratory inhi- 
bition in tumor target cells. J. Exit Med. 169:1543-1555. 
18.  Granger, D.L., R.R.  Taintor, J.L. Cook, and J.B. Hibbs, Jr. 
1980. Injury of neoplastic cells by murine macrophages leads 
to inhibition of mitochondrial respiration. J. Exit Med. 65: 
357-370. 
19.  Granger, D.L., and A.L. Lehninger.  1982. Sites of inhibition 
of mitochondrial electron transport in macrophage-injured  neo- 
plastic  cells. J. Cell Biol. 95:527-535. 
20.  Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fon- 
tecave. 1991. Inactivation of ribonudeotide reductase by nitric 
oxide. Biochem. Biophys. Res. Commun.  179:442-448. 
21.  Kwon, N.S., D.J. Stuehr, and C.F. Nathan.  1991. Inhibition 
of tumor cell ribonucleotide reductase by macrophage-derived 
nitric oxide. J. Exp.  Med. 174:761-767. 
22.  Karupiah, G., and R.V. Blanden.  1990. Anti-asialo-GM1  in- 
hibits vaccinia virus infection of murine ovaries: asialo-GM1 
as an additional virus receptor? lmmunol. Cell Biol, 68:343-346. 
23.  Karupiah, G., T.N. Fredrickson, K.L. Holmes, L.H. Khairallah, 
and R.M.L. Bullet. 1993. Importance ofinterferons in recovery 
from mousepox. J.  Virol. 67:4214--4226. 
24.  Stuehr, D.J., H. Cho, N.S. Kwon, M.F. Weise, and C.F. Na- 
than. 1991. Purification and characterization of the cytokine- 
induced macrophage nitric oxide synthase: an FAD- and FMN- 
containing flavoprotein. Proc. Natl. Acad. Sci. USA. 88:7773- 
7777. 
25.  Yuen, H., J.H. Cox, J.W. Yewdell, J.R. Bennink, and B. Moss. 
1993. Nuclear localization of a double-stranded RNA-binding 
protein  encoded by the  vaccinia  virus  E3L  gene.  Virology. 
195:732-744. 
26.  Zhang, Y., B.-Y. Ahn, and B. Moss. 1994. Targeting of a mul- 
ticomponent transcription apparatus  into assembling vaccinia 
virus particles requires RAP94, an RNA polymerase-associated 
protein. J.  Virol. 68:1360-1370. 
27.  Sodeik, B., G. Griffiths, M. Ericsson, B. Moss, and R.W. Doms. 
1994. Assembly of vaccinia virus:  effects of rifampin on the 
intracellular distribution  of viral  protein p65. J.  Virol. 68: 
1103-1114. 
28.  Xie,  Q:w.,  H.J.  Cho, J.  Calaycay,  R.A.  Mumford,  K.M. 
Swiderek, T.D. Lee, A. Ding, T. Troso, and C. Nathan. 1992. 
2178  Nitric Oxide-mediated Inhibition of Viral DNA Replication Cloning and characterization  of  inducible nitric oxide synthase 
from mouse macrophages. Science (Wash. DC,). 256:225-228. 
29. Bogel, R.G., A.R. Baydoun, J.D. Pearson, S. Moncada, and 
G.E. Mann. 1992. t-Arginine transport is increased  in macro- 
phages generating nitric oxide. Biochem. J.  284:15-18. 
30.  Vodovotz, Y., N.S. Kwon, M. Pospischil,  J. Manning, J. Pail 
and C. Nathan. 1994. Inactivation  of nitric oxide synthase  after 
prolonged incubation of  mouse macrophages with IFN-3~ and 
bacterial lipopolysaccharide.  J. Immunol.  152:4110-4118. 
31.  Granger, D.L., J.B. Hibbs, Jr., F.IL.  Perfect, and D.T. Durack. 
1990. Metabolic fate of L-arginine  in relation to microbiostatic 
capability of murine macrophages.f Clin. Invest. 85:264-273. 
32.  Karupiah, G., B.E.H. Coupar, M.E. Andrew, D.B. Boyle,  S.M. 
Phillips, A. MfiUbacher, R.V. Blanden, and I.A.  Ramshaw. 
1990. Elevated  NK cell responses in mice infected with recom- 
binant  vaccinia virus  encoding  murine  Ib2. J.  Immunol. 
144:290-298. 
33.  Melkova, Z., and M. Esteban. 1994. Interferon-'), severely  in- 
hibits DNA synthesis of vaccinia virus in a macrophage cell 
line. Virology. 198:731-735. 
34.  Natuk, tL.J.,  J.A. Byrne, and J.A. Holowczak. 1986. Infec- 
tion of DBA/2 or C3H/HeJ mice by intraperitoneal injection 
of vaccinia virus elicits activated macrophages, cytolytic and 
cytostatic  for S91-melanoma  tumour cells. Cancer Immunol. Im- 
munoth~  22:197-203. 
35.  Vodovotz, Y., C. Bogdan, J. Paik, Q. Xie, and C. Nathan. 
1993. Mechanisms of suppression of macrophage nitric oxide 
release by transforming growth factor 13. J. Exit  Med.  178: 
605-613. 
36.  Stamler,  J.S. 1994. Redox signaling: nitrosylation and related 
target interactions of nitric oxide. Ceil.  78:931-936. 
37.  Gutteridge, J.M., and B. Halliwell. 1989. Iron toxicity and 
oxygen radicals. Bailliere's Clin. Haematol.  2:195-256. 
38.  Weiss,  G., G. Weruer-Felmayer,  E.R. Werner, K. Grunewald, 
H. Wachter, and M.W. Hentze. 1994. Iron regulates  nitric oxide 
synthase activity by controlling nuclear transcription. J. Exit 
Med.  180:969-976. 
39.  Blanden, R.V. 1974. T cell responses to viral and bacterial in- 
fection. Transplant. Rev. 19:56-88. 
40.  Blanden, R.V., A.J. Hapel, PC. Doherty, and R.M. Zinker- 
nagel. 1976. Lymphocyte-macrophage  interactions and mac- 
rophage activation in the expression of antimicrobial immu- 
nity in vivo. In Immunology  of  the Macrophage. D.S. Nelson, 
editor. Academic Press, New York. pp. 367-401. 
2179  Karupiah  and Harris 